A clinical trial to assess the safety and effectiveness of a new drug, mirikizumab, for moderate to severely active Crohn’s disease.
About this study
The primary purpose of this study is to help answer the following research questions:
- How safe is mirikizumab and are you likely to have any side effects when you take it?
- How effective is mirikizumab as a treatment for Crohn’s disease when other medications may not work?
- How does mirikizumab compare to ustekinumab (a current treatment for Crohn's Disease) or placebo?
Recruitment is now closed.
Ethics
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.
The Clinical Trials Centre (CTC) is a dedicated, purpose-built space where we conduct clinical trials.
The CTC is located on Level 2 South. When you arrive, if you are unsure where to go, talk to one of our friendly volunteers or the information desk staff.